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Interferon (IFN) responses, mediated by a myriad of IFN-stimulated genes (ISGs), are 
the most profound innate immune responses against viruses. Cumulatively, these IFN 
effectors establish a multilayered antiviral state to safeguard the host against invading 
viral pathogens. Considerable genetic and functional characterizations of mammalian 
IFNs and their effectors have been made, and our understanding on the avian IFNs 
has started to expand. Similar to mammalian counterparts, three types of IFNs have 
been genetically characterized in most avian species with available annotated genomes. 
Intriguingly, chickens are capable of mounting potent innate immune responses upon 
various stimuli in the absence of essential components of IFN pathways including retinoic 
acid-inducible gene I, IFN regulatory factor 3 (IRF3), and possibility IRF9. Understanding 
these unique properties of the chicken IFN system would propose valuable targets for the 
development of potential therapeutics for a broader range of viruses of both veterinary 
and zoonotic importance. This review outlines recent developments in the roles of avian 
IFNs and ISGs against viruses and highlights important areas of research toward our 
understanding of the antiviral functions of IFN effectors against viral infections in birds.
Keywords: interferons, innate immunity, antivirals, viruses, avian, interferon-stimulated genes
iNTRODUCTiON
For efficient replication and spread, viruses have to breach a potent and multilayered immune system 
in the host. Occasionally, either due to defects in host immune responses [e.g., complement system, 
interferons (IFNs), and adaptive immunity] or due to successful immune-antagonism, viruses over-
come these antiviral mechanisms and replicate extensively in the host. This results in the engagement 
of diverse cascades of cellular signaling pathways (1). One of the most potent and essential events in 
this host–pathogen battle is the activation of the IFN pathways (1–3).
Three classes of nucleic acid receptors are associated with the activation of the IFN pathways. 
The first category of intracellular pattern recognition receptors (PRRs) is the family of retinoic 
acid-inducible gene I (RIG-I)-like helicases (RLH), which includes RIG-I, melanoma differentiation-
associated gene 5 (MDA5), and laboratory of genetics and physiology 2 (LGP2) (3). A second 
class of PRRs is the family of toll-like receptors (TLR) including TLR3, TLR7, and TLR9, which 
senses extracellular, phagosomal, or endosomal pathogen-associated molecular patterns (1). The 
third category of PRRs is the family of DNA sensors, which include absent in melanoma 2 (AIM2) 
and cyclic GMP-AMP synthetase (cGAS) (4). Upon activation, these PRRs recruit downstream 
signaling molecules and result, directly or indirectly, in the activation of IFN regulatory factors 3 
(IRF3) and 7 (IRF7), as well as activating protein 1 (AP-1) and nuclear factor kappa B (NF-κB) 
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transcription factors (1–4). These are minimally essential events 
to initiate transcription of type I IFN genes and establishment 
of an antiviral state by expressing hundreds of IFN-stimulated 
genes (ISGs) (1, 5) in infected cells.
Extensive structural and functional models have been pro-
posed on the plasticity and dynamics of nucleic acid sensing 
by intracellular PRRs and on the mechanisms of IFN-induced 
antiviral states in mammals (1–4, 6). For a detailed description of 
IFN induction and other innate immune responses in mammals 
against viruses of diverse genetic backgrounds, we refer to other 
in-depth reviews (1, 2, 4, 5, 7, 8).
In this article, we offer a review of the IFN pathways and tran-
scriptional activation of ISGs in different avian species. First, we 
provide an overview of the chicken IFN pathways and highlight 
areas that differ from mammalian IFN induction and signaling. 
Then, we convey a comparative genetic and genomic analysis of 
characterized components of IFN systems among different avian 
species. We conclude with a description of currently studied anti-
viral effectors, their implications for avian diseases, and future 
perspectives.
THe CHiCKeN iFN PATHwAYS: SeNSiNG 
OF viRAL NUCLeiC ACiDS
RLH-Mediated iFN induction
The principles of mammalian IFN pathways (exemplified by 
humans) are in general transferable to chickens. However, there 
are considerable evolutionary divergences in some of the key ele-
ments of the chicken IFN responses to avian viruses if compared 
to their mammalian counterparts. In mammals, RIG-I primarily 
senses 5′-triphosphorylated blunt-ended or double-stranded 
RNA (dsRNA) produced during RNA virus infections. On the 
other hand, MDA5 can be activated by long dsRNA, whereas 
LGP2, which differs from RIG-I and MDA5 in lacking caspase 
activation and recruitment domain domain, can positively regu-
late MDA5 and negatively regulate RIG-I signaling (9, 10). One 
of the most striking features of chickens and other members of 
the order Galliformes (e.g., turkeys) is the absence of RIG-I (11). 
Despite the absence of this key PRR, chickens respond to highly 
pathogenic avian influenza virus (HPAIVs) and mount potent 
type I IFN responses, probably due to cooperative actions of 
MDA5 and LGP2 (10, 12, 13) (Figure 1). Additionally, unlike the 
mammalian MDA5, which senses only long dsRNA, it appears 
that chicken MDA5 can also sense short dsRNA implying that 
chicken MDA5 may compensate, to some extent, the function of 
RIG-I in chickens (13). Recently, Uchikawa et al. have resolved 
the structures of dsRNA-bound chicken LGP2 and MDA5 and 
revealed the plasticity of nucleic acid sensing by these RLH (10). 
It was shown that chicken LGP2 carries two properties of RLH: 
an MDA5-like helicase domain and a RIG-I-like C-terminal 
domain. Chicken LGP2, similar to human RIG-I, is an “end 
binder,” whereas chicken MDA5 is a “stem binder” of dsRNA 
(Figure  1). Based on structural (10) and functional studies 
(12, 13), it is likely that chicken LGP2-mediated enhancement 
of MDA5 sensing of dsRNA is dependent on RNA binding. 
However, it remains to be demonstrated if the mechanisms of 
LGP2-mediated enhancement of MDA5 signaling are similar 
to its mammalian counterparts or if the absence of RIG-I in 
chickens can contribute in the dynamics of cooperative nucleic 
acid sensing in chickens.
It has been hypothesized that the lack of RIG-I makes chick-
ens highly susceptible to RNA viruses, and therefore chickens 
continue to play a central role in the emergence of zoonotic 
influenza viruses (14). However, more research is still required 
to support this generally accepted concept. Although MDA5 and 
LGP2 seem to be sufficient to induce a potent activation of the 
type I IFN pathway, ectopic expression of duck RIG-I in chicken 
cells potentiated the downstream signaling pathway, including 
increased induction of several ISGs such as myxovirus-resistance 
protein (Mx), protein kinase R (PKR), IFN-induced protein with 
tetratricopeptide repeats 5 (IFIT5), or 2′-5′-oligoadenylate syn-
thetase (2′-5′-OAS) (14, 15). These studies indicate that chickens 
have acquired mechanisms to compensate the deficiency of the 
RIG-I signaling molecule; however, it is not possible to assess the 
outcome of nucleic acid sensing in chickens as it would have been 
in the presence of endogenous RIG-I. Nevertheless, chickens are 
one of the most successfully domesticated animal species and are 
immunologically competent in mounting an effective antiviral 
type I IFN state against diverse stimuli.
TLR-Mediated iFN induction
Toll-like receptors are type I transmembrane proteins and have 
a highly conserved architecture in a variety of species, including 
insects, fish, amphibians, birds, and mammals (16). Comparative 
biological approaches revealed that chicken TLRs carry unique 
properties regarding ligand specificity, formation of TLR recep-
tor complexes, and activation of signaling pathways (17). At 
least 10 different TLR members (TLR1–10) have been identified 
in humans (16). Chickens have been shown to have two TLR2 
isoforms (chTLR2 types 1 and 2), two TLR1/6/10 orthologs, and 
single genes for TLR3, TLR4, TLR5, and TLR7. Interestingly, 
chickens do not possess the viral DNA sensor TLR9. However, 
TLR-mediated DNA sensing is mediated by a functional 
ortholog TLR21, which is absent in humans (16). Additionally, 
it has been proposed that chicken TLR8 is non-functional and 
that the chicken genome encodes for an additional TLR gene, 
TLR15, which requires protease-cleavage for activation (18). 
Beside genomic variations, functional differences exist in the 
mechanism of TLR-mediated signal induction in chickens. In 
contrast to humans, lipopolysaccharides failed to stimulate the 
TLR4–TRAM–TRIF pathway in chicken cells (19). Among all 
mammalian TLRs, TLR3, TLR7/8, and TLR9 are known to sense 
viral dsRNA, ssRNA, and DNA molecules, respectively. Since 
in chicken TLR8 is non-functional and TLR9 is absent, only 
TLR3 and TLR7 are involved in the recognition of RNA viruses. 
All TLR family members, with the notable exception of TLR3, 
signal via myeloid differentiation primary response 88 (Myd88). 
TLR3 recruits TIR-domain-containing adapter-inducing IFN-β 
(TRIF) through transmembrane, phagosomal, or endosomal 
compartments (Figure 1). Both modes of TLR-dependent signal 
induction culminate in the activation of the transcription factors 
required for the transcription of type I IFNs.
FiGURe 1 | induction of interferons (iFNs) and establishment of an antiviral state in a model chicken cell. The double-stranded RNA (dsRNA), detected 
by either chicken retinoic acid-inducible gene I (RIG-I)-like helicase (RLH) [melanoma differentiation-associated gene 5 (MDA5) or laboratory of genetics and 
physiology 2 (LGP2) individually or in cooperation] or toll-like receptor (TLR)3 (endosomal, phagosomal, or transmembrane) initiates downstream signaling mediated 
through mitochondrial antiviral-signaling protein (MAVS) or TRIF, respectively. These adaptor molecules then activate the transcription factors IFN regulatory factor 
(IRF)7, nuclear factor kappa B (NF-κB), and activating protein 1 (AP-1) (ATF2/JUN) by orchestrating the assembly of multi-protein complexes. Once activated, IRF7, 
NF-κB, and AP-1 translocate to the nucleus where they stimulate the transcription of, among others, type I IFNs (e.g., IFN-β). The transcribed, translated, and 
secreted type I IFNs initiate the JAK–STAT pathway by both autocrine (depicted in the figure) and paracrine signaling through cognate type I IFN receptor 
recognition. Activated JAK–STAT leads to the phosphorylation of STAT1 and STAT2 molecules, which (together with factors that are currently unknown in chicken) 
results in the formation of the IFN-stimulated gene factor 3 (ISGF3) transcription factor complex. This multifunctional transcription factor then scans and recognizes 
unique IFN-stimulated response element (ISRE) sequences to initiate the transcription of hundreds of chicken IFN-stimulated genes (chISGs), which subsequently 
establish the antiviral state against the invading viruses. Few examples of IFN-stimulated genes (ISGs) along with a summarized description of their functions are 
enlisted in the right panel of the figure. Abbreviations used in the figure and are not described in the main text are as follows: IκB kinase (IKK) epsilon (IKKε), alpha 
(IKKα), beta (IKKβ), and gamma (IKKγ); NF-κB essential modulator (NEMO); TANK-binding kinase 1 (TBK1); inhibitors of NF-κB (IκB), NF-κB subunits p50 and p65; 
activating transcription factor 2 (ATF2); tyrosine kinase 2 (TYK2); Janus kinase 1 (JAK1); signal transducer and activator of transcription 1 (STAT1), and STAT2. “P” 
represents the phosphorylation state of the protein, and dotted lines indicate the involvement of multiple intermediary steps.
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DNA Sensors-Mediated iFN induction
In addition to TLR9-mediated DNA sensing in mammals, 
cytosolic DNA, which can be either non-self DNA or results 
from gross nuclear/mitochondrial damage, can elicit type I IFN 
responses in mammals (9). Currently two major cytosolic sensors 
of DNA have been characterized: the PYHIN family member 
AIM2 and cGAS. Additionally, several proteins have been rec-
ognized as DNA receptors, including Z DNA binding protein 1 
(ZBP1/DAI), the helicase DDX41, and IFI16, another member of 
the PYHIN/HIN-200 family (20, 21). Downstream of these DNA 
sensors, the stimulator of IFN genes (STING) acts as an adapter 
and stimulates type I IFN production through the activation of 
IRF3 and NF-κB transcription factors (9). Although DNA sens-
ing in chickens has not yet been explored in greater detail, genetic 
analysis indicate that the AIM2 gene has been lost independently 
in several animals, including bats and chickens (22). Even in the 
latest Ensembl release of the chicken genome, ZBP1 and IFI16 
were not identified, suggesting fundamental differences in DNA 
sensing mechanisms in chickens. However, it has been shown 
recently that chicken STING can actively sense DNA and in 
cooperation with the mitochondrial antiviral-signaling protein 
induces type I IFN responses independent of RIG-I, interfering 
with the replication of RNA viruses (23). Interestingly, STING-
mediated type I IFN induction was synergistically supported by 
RLHs in chickens (23). This warrants future investigations to 
understand the molecular mechanisms underlining DNA sensing 
in chickens.
TRANSCRiPTiONAL ACTivATiON OF iFNs
Signals initiated by the sensing of viral nucleic acids by RLHs, 
TLRs, or DNA sensors lead to the activation of at least three 
transcription factors (AP-1, IRF3, and NF-κB) in the mam-
malian type I IFN enhanceosome (1). There is scarcity in our 
current understanding of the mechanism and structure of the 
chicken IFN enhanceosome. Comparative genomics analysis 
indicates that chickens are IRF3 deficient (detailed below). 
Currently, it is not known if the presence of functional IRF7 
in chickens compensates for the IRF3 deficiency. Components 
of AP-I and NF-κB transcription factors are encoded in the 
chicken genome, and it is likely that these signaling cascades 
are functionally similar to mammals. Thus, a direct functional 
comparison may be plausible. While inactive, NF-κB, IRF3/IRF7 
(in mammals and IRF7 in chicken), and AP-1 remain in the 
cytoplasm; however, upon stimulation (e.g., nucleic acids) these 
transcription factors get activated and subsequently translocated 
to the nucleus of viral-infected cells by unique mechanisms 
(1). The activation signals result in phosphorylation of IRF7. 
Conformational changes caused by this post-translational 
modification result in IRF7 dimerization and exposure of the 
nuclear localization signal (NLS) (1). This NLS mediates the 
nuclear translocation of IRF7 (1, 24). The inhibitor of NF-κB 
(IκB) retains NF-κB molecules in the cytoplasm. However, upon 
activation by phosphorylation, IκB undergoes ubiquitination 
and proteasomal degradation. Degradation of IκB exposes the 
NLS of NF-κB, which leads to its nuclear translocation (7). 
Phosphorylation of c-jun and activating transcription factor 2, 
two heterodimeric components of AP-1, also causes nuclear 
translocation (1). In the nucleus, these three transcription fac-
tors assemble in a cooperative manner to build a type I IFN 
enhanceosome, which binds to its respective positive regula-
tory domains (PRDs). IRF7, NF-κB, and AP-1 bind to PRD I/
III, PRD II, and PRD IV, respectively, where they induce the 
transcription of type I IFNs and pro-inflammatory cytokines 
(TNF, IL-6, IL-1β, etc.) (25) (Figure 1). These type I IFNs lead 
to transcriptional activation of several hundreds ISGs to mount 
an antiviral state in the host (detailed below).
COMPARATive GeNOMiCS AND 
evOLUTiON BY GeNe LOSS
Even in the updated version of chicken Ensembl (Ensembl release 
85—July 2016, accessed on September 11, 2016), it appears that 
chickens lack IRF3 and IRF9 (depicted in Figure 1), which are 
essential components of the type I IFN system in mammals (1). 
Lately, there have been substantial improvements in the genetic 
analysis and functional characterization of the avian type I IFN 
pathway, particularly in chicken. However, the annotation of the 
chicken genome is not yet completed, leaving open questions 
on the presence or absence of the mammalian homologs in 
avian species. Improved annotation of chicken and other avian 
genomes is required to unambiguously declare the presence 
or absence of a particular gene in the future. This fact can 
be exemplified by a recent analysis of IRF3/7 in the chicken 
genome. The first identified and characterized member in the 
chicken IRF family (named cIRF3) was classified as IRF3 based 
on its sequence and overall functional conservation with cor-
responding IRF3 in other species (26). Availability of updated 
annotation of chicken genome in the Ensembl has filled the gaps 
in the chicken chromosome 5, which encodes for the IRF3/7 
genes and allowed to reevaluate the IRF locus in the chicken. 
Based on the analysis of gene loci in different species including 
human, mouse, dog, and fish (Figure 2A) and previous reports 
(25, 27), it is convincing that the formerly reported cIRF3 is 
actually IRF7. Furthermore, genetic clustering and sequence 
divergence analysis indicate that the chicken IRF7 clusters closely 
with IRF7 of human, mouse, and cattle compared to the IRF3 
of corresponding species (Figure 2B). Therefore, it is suggested 
to use the term chicken IRF7 instead of cIRF3 to avoid any 
misunderstanding in the functional nomenclature between these 
two transcription factors.
Similar to IRF3/IRF7, the currently annotated chicken IRF9 
sequence is both genetically (Figure 3A) and phylogenomically 
(Figure  3B) similar to IRF10 in dog and fish. Comparison 
of the gene orientation and architecture between species in 
which IRF10 is detected (dog and fish) and species in which 
IRF10 is lacking (human and mice) provides direct evidence 
that these crucial elements of the IFN pathways are currently 
incorrectly annotated. In addition, our analysis on global IRF 
family members confirms that the chicken genome lacks any 
significant sequence identity to the mammalian IRF9 orthologs. 
It remains to be explored how chickens still manage to efficiently 
trigger the production of ISGs without the need of IRF9 to 
constitute a functional type I IFN-stimulated gene factor 3 
FiGURe 2 | (A) Genomic architecture along with relative loci around the IRF7 gene in human, mouse, dog, chicken, and fish. The IRF7 genes in the compared 
species are flanked upstream with LRDD gene and downstream with KIAA1542 and RSSF7 genes. Direct comparison of previously identified chicken IRF3 with 
these species indicates that this gene is in fact IRF7. (B) Phylogenetic analysis of IRF3 and IRF7 genes in different species. Based on the clustering patterns and 
sequence homologies, the gene previously identified as “chicken IRF3” clustered closer to IRF7 of other mammals compared to mammalian IRF3. It is therefore 
proposed to rename “chicken IRF3” to “chicken IRF7.” Gene abbreviations used in the figure are dual specificity phosphatase 8 (DSUP8), patatin-like phospholipase 
domain containing 2 (PNPLA2), leucine-rich repeats and death domain containing (LRDD), interferon regulatory factor 7 (IRF7), CTD-binding SR-like protein rA9 
(KIAA1542); Ras association (RalGDS/AF-6) domain family 7 (RSSF7); leucine-rich repeat containing 56 (LRRC56); plakophilin 3 (PKP3).
FiGURe 3 | (A) Genomic architecture of interferon regulatory factor (IRF)10 loci and phylogenetic analysis of IRF9 and IRF10 in human, mouse, dog, chicken, and 
fish. Upstream and downstream genes architecture in the IRF10 of chicken, dog, and fish indicate that this locus is similar to the corresponding locus in human and 
mice, which lack IRF10. Based on this and phylogenetic analysis (B), it is evident that the currently annotated chicken IRF9 is in fact an ortholog of IRF10. Gene 
abbreviations used in the figure are microtubule-associated protein homolog (Xenopus laevis) (TPX2); myosin, light polypeptide kinase 2, skeletal muscle (MYLK2); 
forkhead-like 18 (Drosophila) (FLKHL18); dual specificity phosphatase-like 15 (DUSP15); X Kell blood group precursor-related family member 7 homolog (XKR7); 
chromosome 20 open reading frame 160 (C20orf160); protein O-fucosyltransferase 1 (POFUT1); kinesin family member 3B (KIF3B).
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(ISGF3) complex. However, it is plausible that factor(s) other 
than IRF9 are involved in the formation of an active ISGF3 
complex in chickens. Since type II IFNs-mediate induction of 
ISGs is IRF9-independent, it may be possible that under virus 
infection the gamma-activated sequence (GAS) promoter may 
overwhelm the overall induction of ISGs compared to type I 
and III IFN-induced expression of ISGs.
From these examples, it is clear that our understanding of 
the avian genome is still insufficient to accurately annotate the 
newly identified genes. Efforts have recently become intense 
through the avian consortium to not only characterize the genet-
ics of endangered and newly sequenced bird species but also to 
improve the annotation of the existing genome drafts of avian 
species, especially chicken and duck. As a result of this, a bunch of 
genome sequences from more than 40 avian species was published 
recently (28), providing a valuable source for gene mapping. 
These resources would certainly advance our understanding in 
exploring genes, which are conserved across avian species, and to 
confirm existing genes. A special database (AvianBase) has been 
established to facilitate comparative genomics and immunoge-
netics in avian species (29).
Beside the fact that genes are incorrectly annotated and 
important genomic loci are not characterized in the avian 
species, it is likely that birds have evolutionary lost some 
genes during their domestication and subsequent division into 
required phenotypes (egg-laying versus meat-producing) (30). 
It  requires extensive genetic and genomic investigations to 
confirm gene loss in the evolutionary process of avian species 
and to identify a minimum number of genes that can be readily 
lost from avian genomes without compromising the survivability. 
Although several models can be proposed, loss of genes due 
to “gene function bias” appears to be operative in chicken and 
other avian species (31). Gene function bias refers to the gene 
loss that is preferentially evident in a specific functional category; 
gene loss in gene ontology category of “immune responses” is 
highly probable in mammals compared to other vertebrates (32). 
A similar scenario can be applied to the gene loss in innate 
immune signaling pathways compared to other gene ontology 
categories in avian species mainly due to dispensable functional 
constraints. In this context, different type I IFN-induced proteins 
with tetratricopeptide repeats (IFITs), including IFIT1, IFIT2, 
IFIT3, and IFIT5 (33), have been described to play essential 
roles in nucleic acid sensing, antiviral responses, and protein 
translation in humans. All these functions of IFIT proteins are 
redundant, and thus the protein family is likely under selection 
constraints in chicken where only one IFIT protein (IFIT5) 
has been identified compared to four in human and mice (34). 
In summary, understanding the mechanisms and impacts of 
gene loss would reveal crucial evolutionary aspects of animal 
domestication and may highlight unexplored ways that could be 
exploited both for antiviral therapy and disease control.
evOLUTiON AND NOMeNCLATURe 
OF AviAN iFNs
Phylodynamic analysis of homology-based coding sequences 
of all three types of IFNs (I, II, and III) indicates that these 
evolutionary IFN classes are only distantly related and lack 
apparent sequence homology among each other (Figure  4A). 
However, type I and II IFNs appear to be more closely related to 
each other compared to type III IFN, despite the fact that type I 
and III share functional and signaling homologies.
Although chicken IFNs have functional homologies with their 
mammalian counterparts, gene duplication of each IFN subtype 
varies markedly among different animal species. In all birds 
investigated so far, type II and type III IFNs exist as a single gene 
each (35), whereas in mammals two to four copies of type III IFNs 
have been identified (35). Compared to fish, where generally only 
a single type I IFN homolog is detected, 3 to 10 type I IFN copies 
have been identified on the sex-determining Z chromosome of 
avian species (36–39). The maintenance of type II IFNs in avian 
and mammalian speciation indicates their constant function 
and evolutionary pressures. In both chicken and mammalian 
genomes, the functional transcript of the single type II IFN gene 
is encoded by four exons, and the gene architecture resembles 
that of IL-10-like cytokines.
Direct and parallel comparison of clustering patterns of type 
I and type II IFNs indicates the divergence of IFN-alpha (IFN-α) 
and IFN-gamma (IFN-γ) across mammals, rodents, primates, 
fish, and avian species (Figure 4B). It is evident that chicken IFNs 
and IFN genes of other vertebrates included in this evolutionary 
tree cluster distinctly from the fish IFNs. However, both fish and 
chicken type I and type II IFNs formed separate clades with mark-
edly high resolution (bootstrap value of >90%). These clustering 
patterns may support the evolutionary and structural architecture 
of at least type I IFNs in different vertebrates, where fish encodes 
for five exons compared to single exon in birds and mammals. 
This is postulated to be due to the retrotransposition events in 
which four exons were lost between divergence of tetrapods and 
radiation of amniote lineages (37).
Consistent with vertebrate evolution, there are insufficient 
relationships between type I and type II IFNs in avian and 
mammalian species (Figures  4A,B). Thus, it is concluded that 
mammalian and avian type I IFNs evolved independently by 
gene duplication of a progenitor after segregation of mammals 
and birds (38, 39). Therefore, the avian type I IFNs are no true 
orthologs of their mammalian counterparts, and the nomencla-
ture used for mammalian type I IFNs is strictly not appropriate 
for avian species. This is further supported by the level of genetic 
and functional differences between mammalian and avian type I 
IFNs (detailed below).
AviAN iFNs
Based on their receptor specificity, sequence homology, and 
nature of ISG induction, IFNs are divided into those that bind 
IFNαR1 and IFNαR2 (type I IFNs), those that interact with recep-
tors complexes of IFNγR1 and IFNγR2 (type II IFNs), and those 
that interact with heterodimeric receptor complex of IL-28Rα 
and IL-10Rβ (type III IFNs or IL-28/29). Our understanding 
of the avian IFN pathways is gradually increasing, and recently 
several significant contributions have been made to characterize 
existing genes (40–42) and previously identified IFNs, especially 
in chicken. In the following sections, our current understanding 
FiGURe 4 | Phylogenetic analysis of interferon (iFN) genes of mammals (including rodents, primates, and domestic animals), avian, and fish species. 
(A) The open reading frames of type I, II, and III IFN genes were manually extracted from public databases and were aligned in BioEdit. The phylogenetic tree was 
constructed by MEGA6 software using the Kimura-2 model with 1,000 bootstrap replicates. The three types of IFNs clustered distantly and were labeled according 
to their clustering patterns. Approximate branching position was marked with a representative animal in the class. Only bootstrap values higher than 50 are shown. 
(B) Parallel comparison of type I and type II IFNs. Type III IFNs have been identified in limited numbers of species, and thus direct comparison was avoided. 
Clustering pattern of type I IFNs were linked to the type II IFN gene of the corresponding species for comparison purposes, and a representative animal image was 
shown to illustrate the clustering pattern.
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TABLe 1 | Summary of characteristics demonstrated for chicken iFNs.
iFN 
type
Known 
variants
Chemical properties Receptor 
subunits
Antiviral activitiesa Primary 
expression of 
cytokine
Location Promoter 
for iSGs
Reference
I IFN-α, IFN-β Acid and heat stable IFNAR1
IFNAR2
MDV, IBDV, IBV, influenza Fibroblasts Z chromosome ISRE (43–47)
II IFN-γ Sensitive to low pH (2) and 
heat (65°C)
IFNGR1
IFNGR2
NDV, MDV, influenza Immune cells Chromosome 1 GAS (48, 49)
III IFN-λ Heat stable IL-28Rα
IL-10Rβ
NDV, influenza, IBV Epithelial cells Scaffold 
AADN04001262.1
ISRE (50–52)
aThese are few examples of pathogens against which antiviral activities of the cytokine have been demonstrated.
IFN, interferon; ISGs, IFN-stimulated genes; IFN-α, IFN-alpha; IFN-γ, IFN-gamma; MDV, Marek’s disease virus; IBDV, infectious bursal disease virus; IBV, infectious bronchitis virus; 
NDV, Newcastle disease virus; ISRE, IFN-stimulated response element; GAS, gamma-activated sequence.
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on chicken IFNs and comparative genomics in other avian spe-
cies will be discussed. Several known features of chicken IFNs are 
summarized in Table 1.
Avian Type i iFNs
In contrast to the numerous members of type I IFNs in mam-
mals (IFN-α, IFN-β, IFN-ε, IFN-κ, IFN-ω, IFN-δ, and IFN-τ), 
so far only two serologically distinct, intron-less, acid and heat 
stable type I IFNs (IFN-α and IFN-β sharing nt homology of 
57%) have been identified in avian species on the short arm 
of Z (sex) chromosome (53). Unlike IFN-β, which is encoded 
only by a single gene copy, chicken IFN-α exists as a family of 
several genes (Table  1). Although there is low overall amino 
acid identity between avian and mammalian IFN-α protein 
sequences (24%), a core region in the chicken IFN-α carries 
four of six conserved cysteine residues, an α-helix and a high 
sequence identity (80%) compared to mammalian IFN-α pro-
tein (Figure 5A).
Moreover, recombinant goose IFN-α has been shown to carry 
partial cross-species antiviral properties (55, 56). These results 
indicate that type I IFNs have attained certain levels of functional 
flexibilities (56). Nevertheless, all type I IFNs are known to be 
involved in inducing an antiviral state, inhibiting cell prolifera-
tion, modulating cell fate, and mediating cell differentiation and 
migration (57). To accomplish the primary function of IFNs, it 
is essential for these cytokines to bind to their respective recep-
tors. Receptors for type I IFNs (IFNAR1 and IFNAR2) have been 
sequenced in chicken (58); however, little information is available 
about their functional domains and their crucial roles in type I 
IFN signaling.
Among avian type I IFNs, most of the research has been 
conducted on chickens, and IFN-α has been identified and more 
extensively characterized than IFN-β in different avian species 
(59) (Figures  5A,B, respectively). Chicken IFN-α and IFN-β 
genes were first identified from a cDNA library of aged chicken 
embryo cells, and subsequent analysis indicated the functionally 
and evolutionarily conserved properties compared to mam-
malian type I IFNs (60). Several recent studies have mapped the 
expression dynamics of chicken type I IFNs triggered by differ-
ent stimuli (60–63). Collectively, type I IFNs (especially IFN-α) 
are potent antiviral agents and can ameliorate viral infections 
including Marek’s disease virus (MDV), infectious bursal disease 
virus (IBDV), infectious bronchitis virus (IBV), and HPAIV in 
different avian species (43–47). These antiviral properties of type 
I IFNs are identified not only in vitro but also in ovo and in vivo 
(43, 47).
Antiviral properties of type I IFNs are essentially mediated 
by the induction of ISGs. Both chicken IFN-α and IFN-β bind 
to the same IFN receptors (IFNAR1 and IFNAR2). However, 
it has been recently found that IFN-α and IFN-β differentially 
regulate ISGs in chickens (62). The antiviral state induced by 
chicken IFN-α was observed to be significantly more potent 
than that induced by chicken IFN-β, although both share genetic 
and structural similarities (64). These differential effects can be 
explained by differential binding affinity of IFN-α and IFN-β 
for the IFNAR1 and IFNAR2 (44). This hypothesis is further 
supported by a recent ontological study on the development of 
the chicken type I IFN system in which a markedly stronger 
upregulation of IFNAR1 as compared to IFNAR2 was observed 
during embryonic development in chicken lung and spleen 
cells (65). Since IFN-α and IFN-β differentially regulate the 
transcriptional activation of ISGs, it is imperative to consider 
that 5′ upstream regions of the chicken IFN-α genes lack 
NF-κB-binding sites and carry several binding sites for IRF 
members in their promoters regions (64). Moreover, observed 
differences in the ISGs induced by chicken IFN-α and IFN-β 
could be due to intrinsic functional components of the cell lines 
under investigation. For instance, type I IFNs induces TLR3 
upregulation in the chicken fibroblasts cell line DF-1, whereas 
this induction was not observed in the chicken macrophages 
cell line HD11 (66). It cannot be excluded that constitutively 
primed cells may respond better to IFN-α compared to IFN-β, as 
has been observed in human lymphocytes that produce IFN-α, 
without the need to produce IFN-β, by viral infections (67). In 
conclusion, differential regulation of type I IFN-induced ISG 
signaling can be multifactorial and represents an interesting 
area for future investigations on the avian innate immunity.
Type I IFNs, especially IFN-α, have been characterized and 
assessed for their antiviral activities against IFN-sensitive viruses 
in various additional avian species. The duck type I IFNs were first 
detected in duck embryo fibroblasts (DEFs) after infection with 
high doses of reovirus serotype 3 (strain Dearing). Exogenous 
expression of this IFN blocked the release of avian RNA tumor 
virus particles in B77 virus-transformed DEFs (68) and showed 
FiGURe 5 | (A) Structural and amino acid sequence homologies between type I interferons (IFNs) in different avian species. Alignment and sequence homology of 
avian IFN-alpha (IFN-α) [(A), top panel] and avian IFN-beta (IFN-β) [(A), bottom panel] amino acid sequences. Putative sites for IFN-α binding to IFNAR1 are marked 
with heart symbol, whereas the sites that are important for binding to IFNAR2 are marked with star sign. In comparison to mammals, sites required for interaction of 
IFNs with IFNARs are more variable among avian species (54). The previously reported signal peptides are underlined in both IFN-α (top) and IFN-β (bottom) 
sequences (54). (B) A modeled cartoon structure of human and chicken IFN-α. IFN-α protein structures were predicted using I-TASSER online tool and were 
annotated and aligned in MacPyMOL. Similar to human IFN-α (PBD ID: 1ITF), chicken IFN-α carries five helices and is structurally similar to human IFN-α. Direct 
structure comparison between human (mammalian) and chicken (avian) IFN-α proteins indicate that the chicken IFN-α protein carries five alpha-helices, which are 
considered crucial for the functionality of type I IFNs in mammals.
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antiviral effects for chronic hepatitis B virus infections (69). 
Recently, IFN-α has been identified and expressed in cells from 
the red-crowned crane (70), and an initial bioassay indicated its 
antiviral activities against vesicular stomatitis virus (VSV) in 
heterologous chicken fibroblasts. IFN-α has also been cloned 
from geese and turkeys, and initial functional insights including 
the antiviral actions have been determined (55, 71).
The results obtained so far on avian type I IFNs indicate 
that these cytokines are functionally, structurally (Figure  5B), 
and evolutionary related to mammalian IFNs and may have 
originated from common ancestor genes. However, extensive 
studies are required to identify other homologs of type I IFNs 
in all avian species, their mechanisms of action, how they exert 
individual and cumulative antiviral effects, and their potential for 
cross-species reactivity.
Avian Type ii iFNs
Interferon-gamma is the only member of type II IFN in birds 
and mammals and serves as a bridge between innate and adaptive 
immunity. IFN-γ plays a crucial role in regulating the maturation 
and differentiation process of several immune cells and activates 
T helper 1-type immune responses (3). Due to these unique 
properties, significant research has been conducted to map the 
antiviral potential and mechanistic effects of IFN-γ in chicken, 
and considerable information is also available for other avian spe-
cies. Direct gene comparison and evolutionary analysis of avian 
IFN-γ genes clearly demonstrate the significant identity both at 
the genome architecture and at the core functional transmem-
brane domain levels (Figures 6A,B). Receptors for type II IFNs 
have been identified and genetically characterized in chicken 
(72, 73). It is interesting to observe that unlike IFN-γ receptor 
β-chain (IFNGR2), the IFN-γ receptor α-chain (IFNGR1) of 
chicken has a 110 amino acid domain of a fibronectin type III 
(59). The LPKS and YDKPH motifs in the intracellular domain, 
required for the interaction with Janus kinase 1 (JAK1) and signal 
transducer and activator of transcription 1 (STAT1), were found 
to be conserved between avian and mammalian IFNGR1 (59). 
From two studies conducted by the same group, it was found 
that chicken IFNGR1 was highly expressed in spleen, thymus, 
peripheral blood lymphocytes (PBLs), cecal tonsil lung, and 
liver, whereas chicken IFNGR2 was highly expressed in spleen, 
thymus, PBLs, cecal tonsil, and muscle (72, 73). Beside these 
FiGURe 6 | Structural and amino acid sequence homologies between type ii and type iii interferons (iFNs) in different avian species. (A) Protein 
sequence alignment of avian type II IFN (IFN-γ). (B) Predicted structure of chicken IFN-γ. (C) Protein sequence alignment of avian type III IFN (IFN-λ). (D) Predicted 
structure of chicken IFN-λ. Sequence alignments show that type II and type III IFNs are significantly conserved among avian species and may indicate interspecies 
cross-reactivity. Previously identified or predicted signal peptides are underlined in both IFN-γ (A) and IFN-λ (C) sequence alignments (54). These structures were 
predicted using I-TASSER online tool and were annotated using MacPyMOL. Structurally, these IFNs are well aligned with that of human IFNs (data not shown).
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fundamental investigations, our current understanding is limited 
to the nature and genetics of IFNGRs in avian species, which 
warrants extensive future research to underpin the mechanisms 
of the IFN-γ-induced antiviral states.
Chicken IFN-γ was first amplified from a cDNA expression 
library generated from a T cell line (CC8.1h) in 1995 (74). Chicken 
IFN-γ is encoded by a single gene located on the chromosome 1 
and shares >30% amino acid homology with mammalian IFN-γ 
genes (74). Genetic and functional studies indicated its actions to 
be conserved as compared to mammalian IFN-γ-proteins (74). 
Unlike type I IFNs, IFN-γ is sensitive to low pH (2) and heat 
(65°C) (74). Several studies demonstrate that small interfering 
RNA mediated gene silencing of the IFN-γ to ascertain its anti-
viral effects (75, 76). Likewise, recent studies have clearly defined 
the antiviral role of IFN-γ and its adjuvant properties against 
viruses of diverse genetic nature including Newcastle disease 
virus (NDV), MDV, and influenza viruses (77–79). Similar to its 
mammalian counterparts, chicken IFN-γ also induces MHC class 
I and class II molecules and mediates the production of nitric 
oxide, which is an important inhibitory mechanism for viruses 
(80). These studies have collectively highlighted the potential and 
emerging roles of chicken IFN-γ in vaccine-conferred antiviral 
immunity.
After the initial identification of duck IFN-γ from a cDNA 
library generated from primary duck hepatocytes and demon-
stration that duck IFN-γ inhibits duck hepatitis B virus in a dose-
dependent manner (81, 82), it has been found that duck IFN-γ 
shares both structural and functional identities with chicken 
IFN-γ (83). In contrast to chicken and duck IFN-γ, goose IFN-γ 
exerts only a weak antiviral state, which may indicate distinct 
biological activities between these two species (55). It is interest-
ing to observe that the cross-species reactivity of type II IFN has 
been shown to be considerably higher compared to any other IFN 
types (48). For instance, recombinant pigeon and turkey IFN-γ 
was found to be functionally active in chicken cells (48, 49). 
In conclusion, despite of structural and functional similarities 
between type II IFNs in different avian species, drivers of dif-
ferential antiviral activities and molecular mechanisms of diverse 
immunological responses induced by type II IFNs are yet to be 
determined in different avian species.
Avian Type iii iFN
While at least four IFN-λ genes (IFN-λ1, IFN-λ2, IFN-λ3, and 
IFN-λ4) were identified in humans (84), only one functionally 
conserved IFN-λ copy was identified in chicken (50, 51). Chicken 
IFN-λ shows high sequence identity with human IFN-λ3. The 
antiviral activities of type III IFNs are dependent on the heterodi-
meric IFN-λ receptor, which is composed of the IFN-λ-specific 
IL-28Rα (IFNLR1) chain and the IL-10Rβ (IFNLR2) chain in 
mammals. Expression of chicken IL-28Rα was also shown to 
be indispensable for the antiviral activity of chicken IFN-λ (52). 
Similar to mammals, expression of chicken IL-28Rα appeared to 
be highest on epithelial cells and in epithelium-rich organs (52). 
Moreover, avian type III IFN might be functionally conserved 
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compared to those of mammalian species, likely playing a pre-
dominant role in the antiviral defense of epithelial barriers (85). 
This view is further supported by antiviral activity of chicken 
IFN-λ against several respiratory pathogens, including NDV, 
IBV, and influenza viruses in vivo, in ovo, and in epithelial cells 
and in tissue culture systems (52). In contrast, chicken IFN-λ 
showed only low to moderate antiviral effects on non-epithelial 
cells, such as primary chicken embryo fibroblasts (CEFs), DF-1 
chicken fibroblasts, or the chicken macrophage cell line HD11 
(50, 52). This is in line with the assumption that the expression 
of chicken IL-28Rα is low or absent in most non-epithelial cell 
types (52).
In contrast to chicken IFN-γ, which induces high levels of 
nitric oxide in immune cells, IFN-λ as well as IFN-β induces 
significantly lower levels of nitric oxide in different non-epithelial 
cell types (50). Recently, it has been shown that chicken IFN-λ 
inhibits influenza virus replication in CEFs; however, it requires 
higher doses for achieving effective antiviral activities and to 
induce ISGs as compared to chicken IFN-γ and IFN-β (63).
In addition to chicken IFN-λ, Yao and colleagues have recently 
cloned IFN-λ from Pekin ducks and have found that duck IFN-λ 
is genetically and structurally highly conserved to other avian 
and mammalian IFN-λ genes (86). Recombinant duck IFN-λ was 
capable of inducing ISGs (2′-5′-OAS and Mx) in primary duck 
hepatocytes. Only very little information is available on IFN-λ 
homologs in other avian species (Figures 6C,D).
A CROSS TALK BeTweeN TYPe i, ii, 
AND iii iFNs
Following production, IFNs initiate the induction of ISGs by 
binding to their respective IFN receptors in autocrine and parac-
rine manners (1). Despite the fact that all types of IFNs play dis-
tinct and dedicated roles, a significant functional and regulatory 
overlap among all types of IFNs has been identified. Type I IFNs 
(IFN-α/β in the case of chickens) are produced from fibroblasts, 
whereas the antiviral actions of type III IFNs are mainly restricted 
to epithelial cells (52). These cell-specific roles are probably linked 
to the expression of cognate receptors in these organs for their 
importance in specific system.
It has been shown in mammals that type I and III IFNs initiate 
the same signaling pathway through phosphorylation of STAT1 
and STAT2 heterodimers possibly by tyrosine kinase 2 (TYK2) 
and JAK1 kinases (1) (Figure 1). However, type II IFNs trigger 
ISGs’ induction via the activation of STAT1 homodimers by 
JAK1 and JAK2 kinases (1). Several protein phosphatases and the 
suppressors of cytokine signaling (SOCS), such as SOCS1 and 
SOCS3, were found to be involved in negative regulation of STATs 
phosphorylation (87). Although there are discrete downstream 
JAK–STAT signaling pathways for different type of IFNs, it has 
been shown that antibody-based neutralization of type I IFNs, 
or their receptors, attenuate the type II IFN responses. This 
may be linked to possible common receptor components or to 
the priming effect of type I IFNs on the expression of common 
transcription factors (e.g., STAT1) (1), which could cross-link the 
signaling between the three types of IFNs. Most components of 
JAK–STAT signaling pathway have been identified in chickens 
(Figure 1) and ducks, indicating possible functional homologies 
between mammals and avians.
To initiate the transcriptional activation of ISGs and other 
cytokines, type I and III IFNs mediate the recruitment and 
phosphorylation of IRF9 and STAT1/STAT2 heterodimer, to 
constitute a functional ISGF3 (1, 88). Type II IFNs initiate the 
formation of a STAT1–STAT1 homodimer to assemble GAF, 
without the need of IRF9. Upon nuclear translocation, ISGF3 
and GAF bind to IFN-stimulated response elements (ISREs) (88) 
or GAS element, respectively (1). These events consequently lead 
to the transcriptional activation of hundreds of ISGs (Figure 1). 
In mammals, IRF9 is required for ISRE promoter activation (1). 
However, as indicated before, this transcription factor has not yet 
been identified in chickens, raising the question of alternative 
mechanisms of types I and III IFN-mediated ISG induction.
Regardless of the nature of their induction, ISGs play fun-
damental roles in a wide range of cellular activities, including 
transcriptional and translational regulation of immune responses 
(89, 90). The collective actions of these ISGs counteract viral rep-
lication and provide an antagonistic environment to limit virus 
propagation and spread (detailed below).
AviAN ANTiviRAL eFFeCTORS
Binding of type I, II, and III IFNs to their respective receptors 
leads to the initiation of signaling cascades that culminate in 
the induction of distinct set of >300 ISGs (at least in human, 
mouse, and rats) (1, 5). These ISGs create an antiviral state and 
safeguard the host with multilayered, often synergistic, and 
cumulative actions (91). ISGs act on several stages of the viral 
replication cycle, ranging from virus entry to virus release (91). 
Some of these ISGs are PRRs that potentiate virus detection 
and thus modulate IFN induction through an amplification 
loop resulting in enhanced IFN production and hence more 
efficient virus inhibition (1, 91). Some ISGs have direct anti-
viral roles by acting at the level of host protein translation, 
post- transcriptional, and post-translational modifications. 
Significant advancements have been made in screening and 
mapping the antiviral roles of many ISGs against a broad range 
of viral pathogens (5). However, similar investigations have just 
been started in avian species. High throughput host gene expres-
sion profiling strategies, such as next-generation sequencing 
and microarray transcriptome analysis, have provided a snap-
shot of the ISGs that might have essential roles against avian 
viruses (92, 93). While the majority of these identified ISGs 
are still uncharacterized, a comparative knowledge of chicken/
avian ISGs with their mammalian counterparts indicates that 
some of these ISGs are genetically and functionally conserved 
and are likely crucial for the control of viral infections. Of the 
hundreds of ISGs identified in mammals, only few have been 
genetically and functionally characterized in chicken. These 
include IFN-inducible transmembrane protein (IFITM)3 (94), 
which can inhibit virus entry; Mx (95), which can block early 
stages of virus replication; viperin (40), which can inhibit virus 
release; ZAP (41), which can weaken viral mRNA translation; 
2′-5′-oligoadenylate synthetases (2′-5′-OAS/RNaseL) (54), 
which can cleave viral RNA transcripts; and PKR (62), which 
12
Santhakumar et al. Antiviral Effect of Avian Interferons
Frontiers in Immunology | www.frontiersin.org January 2017 | Volume 8 | Article 49
can sense TLR-mediated immune responses (Figure 1). To our 
knowledge, these are the only ISGs that have been, to date, 
functionally characterized in chickens. A brief description of 
individually known avian ISGs is provided below.
CCCH-Type Zinc Finger Antiviral Protein 
(ZC3HAv1)
The antiviral action of ZC3HAV1 (ZAP) in mammals is mediated 
by its specific binding to the ZAP-responsive element encoded 
within viral mRNA (96). This binding recruits the host cellular 
degradation machinery to disable the viral mRNA translation 
specifically without any damage to host mRNA (96). Recently, 
chicken ZAP has been genetically characterized, and it appeared 
that the antiviral role of ZAP is probably evolutionarily conserved 
among vertebrates (41). In contrast to the presence of a long and 
a short ZAP isoforms in mammals, only one isoform (tentatively 
suggested to be the long isoform) has been found in chickens (41). 
The shorter isoform in mammals has recently been recognized as 
a positive regulator of the RIG-I pathway (97). While it remains 
to be finally clarified that chickens lack a shorter ZAP isoform, it 
may have been coevolutionary lost along with the RIG-I ortholog 
in chicken (41). The chicken ZAP gene can be prominently 
induced by polyinosinic:polycytidylic acid (poly I:C, a synthetic 
dsRNA analog) and type I IFN treatment in avian cells, suggest-
ing that ZAP is an ISG (41). Moreover, the potential relevance of 
chicken ZAP in viral pathobiology is likely due to its upregulation 
in influenza H5N1 and IBDV-infected chickens (41). However, 
future studies are required to investigate whether all avian species 
have this protein and whether its functions are similar to those of 
its mammalian counterparts.
iiFiTM Members
Several members of the IFITM family including IFITM1, IFITM2, 
IFITM3, and IFITM5 have been identified in humans (34). They 
are differentially expressed upon stimulation by type I and type II 
IFNs, either in the majority of body tissues (IFITM1, IFITM2, and 
IFITM3) or exclusively in osteoblasts (IFITM5) (34). Recently, 
functions of these ISGs have been studied extensively against 
viruses of medical, zoonotic, and veterinary importance (34). 
IFITM proteins inhibit viral infection by blocking cytoplasmic 
entry (98). Mechanistically, IFITM proteins suppress viral mem-
brane fusion due to reduced membrane fluidity and thus form-
ing curvature in the outer leaflets of cell membranes (99); or by 
disturbing the intracellular cholesterol homeostasis by preventing 
association of vesicle-membrane-protein-associated protein A 
with oxysterol-binding protein (100). Recently, three chicken 
IFITM proteins (IFITM1, IFITM2, and IFITM3) have been 
genetically characterized, and IFITM2 and IFITM3 have been 
functionally characterized (94). Despite of low sequence homol-
ogy, human and chicken IFITM2 and IFITM3 are functionally 
conversed and are potent inhibitors of influenza and lyssaviruses 
(94). However, it remains to be determined whether the antiviral 
mechanisms of chicken and mammalian IFITM members are 
similar. Recently, it has been demonstrated that the duck IFITM3 
confers antiviral activities against influenza viruses and that this 
action is independent of the N-terminal region of IFITM3 (101). 
Interestingly, several structural divergences were observed in the 
duck IFITMs probably owing to host–viral coevolution. Different 
publically available databases clearly indicate the presence of 
IFITM member proteins in several other avian species with 
variable levels of sequence and possible functional similarities. 
This leaves an opportunity to identify and characterize these 
important effector proteins of the innate immune system and to 
map their functions in avians.
Myxovirus-Resistance Proteins
Myxovirus-resistance proteins are GTPases that are key antiviral 
effector proteins of the type I and type III IFN pathways. In 
mammals, two major forms of Mx protein exist, namely MxA- 
and MxB-like Mx proteins (102–105). Mammalian MxA-like 
proteins, such as human MxA or mouse Mx1, are known to be 
potent inhibitors of influenza and a broad range of other viruses 
(102–104, 106). In contrast, the human MxB has only recently 
been shown to inhibit retrovirus infections (107). To date, only 
one lineage of Mx genes is known in birds (108, 109). Avian 
Mx proteins appear to be structurally similar to its mammalian 
counterparts, containing a GTP-binding and a leucine zipper 
motif, but they possess a unique N-terminal part that lacks 
significant homology with mammalian Mx proteins (109–111). 
Chicken Mx is distributed mainly in the cytoplasm (110, 112), 
while duck Mx has been shown to be located in cytoplasm and 
nucleus (111). To date, the GTPase activity for chicken Mx 
has not been demonstrated (113), and conflicting results have 
been reported on the antiviral activity of avian Mx proteins. In 
its first description, chicken Mx was reported to lack antiviral 
functions against a broad range of RNA viruses including influ-
enza A viruses, Thogotovirus, VSV, and Sendai virus (110). A 
subsequent study identified a high degree of genetic diversity 
in the chicken Mx gene (114). Functional assays demonstrated 
that chicken Mx alleles carrying an asparagine at amino acid 
position 631 (Mx-Asn631) possess antiviral activity against VSV 
and HPAIV H5N1 in transfected mouse cells, whereas alleles 
carrying a serine at this position (Mx-Ser631) lacked antiviral 
activity (114, 115). While some studies confirmed the antiviral 
effects of Mx-Asn631 against VSV and NDV in cell culture 
(116–118), others failed to demonstrate Mx-mediated resistance 
of both Mx variants against influenza, NDV, and Thogotovirus 
using comparable approaches (112, 113, 119, 120). Artificial 
translocation of chicken Mx to the nucleus did not enhance 
its antiviral activity (112). In vivo studies either did not dem-
onstrate an effect of the polymorphism at position 631 on the 
clinical course of an experimental HPAIV H7N1 infection (121) 
or reported an association of Mx–Asn631 with slightly reduced 
mortality and morbidity following HPAIV H5N2 infections of 
chickens (120). Overexpression of duck Mx in murine cells did 
not result in enhanced antiviral activity against VSV and HPAIV 
H7N1 (111).
In summary, the functional characteristics of avian Mx pro-
teins, their role in innate antiviral immunity, and the effect of 
genetic polymorphisms are still poorly understood and require 
further investigations. It is possible that, similar to human MxB, 
avian Mx proteins possess unequivocal antiviral activities against 
viruses substantially differing from the few RNA virus families, 
which have been tested so far.
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Protein Kinase R
Protein kinase R is a serine/threonine protein kinase and consists 
of two domains that are functionally independent; the dsRNA-
binding N-terminus and the catalytic C-terminus domains (122). 
PKR was first identified during investigations on the translation 
inhibition of viral and cellular mRNAs in vaccinia virus (VV)-
infected mammalian cells (123). In an inactive form, PKR local-
izes in the nucleus and upon activation, mediated through viral 
dsRNA recognition, oxidative stress, growth factors, cytokines, 
and cellular proteins such as PKR-associated activator, or follow-
ing the stimulation of TLRs, phosphorylates the eukaryotic initia-
tion factor 2. This action impairs the guanine nucleotide exchange 
reaction and thus inhibits translation of mRNA in infected cells 
(124, 125). Although different viruses, including influenza virus, 
herpes simplex virus type I, and hepatitis C virus, encode for 
counteracting factors to inhibit PKR actions, this kinase can still 
surpass and can exert antiviral activities.
It has been demonstrated that chicken PKR carries all 
features characteristic for RNA-binding proteins and kinase 
families (126). Similar to the chicken Mx gene, chicken PKR 
is also polymorphic and confers antiviral effects against VSV 
(126). However, in an in vivo study, transcriptionally upregu-
lated PKR failed to protect chickens from highly pathogenic 
H5N1 infection (127).
Similar to Mx and several cytokines, it is likely that specific 
SNPs may define the function of PKR in a specific and understud-
ied avian population. Although PKR is one of the first identified 
PRRs, our understanding of its function is still incomplete even 
in mammals. In this regards, a novel role of PKR in specifically 
maintaining the integrity of newly synthesized IFN mRNAs has 
been recently described (128), further highlighting the need for 
future research (124).
2′-5′-Oligoadenylate Synthetase
In an attempt to understand the molecular mechanism of PKR-
induced inhibition of protein synthesis during VV replication, 
another enzyme called 2′-5′-OAS was identified in mouse (129). 
Interestingly, 2′-5′-OAS mRNA has been detected in erythrocytes 
and immature red blood cells in several avian species (chicken, 
goose, and pigeon) (130, 131). The same group also identified 
the existence of two alleles of the 2′-5′-OAS gene in chickens 
(132). They found that 2′-5′-OAS A/B allele encodes for 58 and 
54 kDa synthetases, whereas chickens carrying 2′-5′-OAS A/A 
alleles produce only a single 58 kDa protein (133). Expression 
of each of these two chicken 2′-5′-OAS alleles has been revealed 
to be age-dependent (133). The stability and persistence of 
2′-5′-OAS are determined by the ubiquitin-like domain in the 
carboxyl-terminus of the 2′-5′-OAS (134). Interestingly, basal 
2′-5′-OAS expression was systemically detected in chicken 
embryos independent of stimuli (130). However, a significant 
induction of 2′-5′-OAS was observed in IFN-treated chicken 
embryo cells (135).
More recently, the antiviral activity of chicken 2′-5′-OAS 
against West Nile virus was demonstrated in a replicon assay in 
mammalian cells (136). Notably, this assay provides the ability 
to investigate the effect of allele-specific antiviral actions of 2′-
5′-OAS against avian viruses with diverse genetic backgrounds.
viperin
Viperin is one of the most important IFN effectors in mam-
mals and confers antiviral activity by inhibiting the trafficking 
of soluble viral proteins in the cytoplasmic compartments. 
Limited availability of the viral components may restrict viral 
spread (137, 138). Moreover, several studies have also found 
that mammalian viperin impairs virus replication and restricted 
viral budding (139). The recently characterized chicken 
viperin exhibits mammalian-like domains, including a variable 
N-terminal variable region spanning 77 amino acids, a central 
radical SAM domain, and a C-terminal conserved region (40). 
While chicken viperin was significantly induced by influenza 
viruses and IBDV as well as by different innate immune recep-
tor ligands both in vitro and in vivo (40), its antiviral potential 
requires future investigations. Since chicken viperin carries 
leucine zipper and radical SAM motifs, which are known to be 
essential for viperin-induced antiviral activities in mammals, it 
is conceivable that chicken viperin has functional conservation 
with the mammalian counterpart.
CONCLUSiON AND FUTURe OF AviAN 
iNNATe iMMUNiTY ReSeARCH
The currently available information on the immunogenetics of 
avian IFNs is a basis for future research aimed to understand 
the molecular mechanisms of IFN induction, associated factors, 
and to identify uncharacterized IFNs in different avian species, 
which differ significantly in their IFNs pathways and harbor 
viruses of both veterinary and medical importance. Because of 
existing functional and genetic differences, it might be needed 
to revise the nomenclature of avian IFNs to truly represent their 
origins and actions. Although IFNs were discovered by Isaacs and 
Lindenmann in chicken cells (140), knowledge on the dynam-
ics and plasticity of chicken IFNs and their antiviral activities is 
markedly scarce compared to their mammalian counterparts. 
An important and evolutionary crucial area of research is to 
understand the potent innate immune responses in chicken in the 
apparent absence of essential components of IFN pathways, such 
as RIG-I, especially in chicken and turkey. Recent availability of 
genomics data on different avian species has significantly advanced 
comparative immunogenetics studies. However, extensive efforts 
are required to improve the current genome annotation of widely 
used poultry species (chicken, duck, and turkey) and to effectively 
characterize existing gaps in functionally important genomic loci. 
Investigations on functional implications of avian ISGs have been 
started; however, next-generation strategies would be required to 
map the antiviral or possible proviral roles of these IFN effectors. 
Most actions of ISGs have been studied using single isoforms of 
the ISGs exploiting either ectopic expression or silencing meth-
ods. Approaches such as CRISPR/Cas9 knockout/knockin will 
be required for future investigations on effective mapping avian 
ISG and their functions. One of the aspects that might require 
future efforts is to identify the overlapping antiviral roles of ISGs 
and the molecular combinatorial networking in these antiviral, 
or proviral, properties. Since silencing of individual ISGs leads 
to observable differences in virus pathobiology, these appear to 
be valuable targets for the development of potential therapeutics 
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for a broader range of viruses, and for vaccine production. 
In this regard, human IFNs have been successfully applied for 
the treatment of virus-induced human diseases; however, the 
clinical potential of chicken or other avian IFNs has not yet 
been exploited. These applications may hold options for future 
economical antiviral therapy not only in commercial poultry but 
also in companion birds.
AUTHOR CONTRiBUTiONS
Conception and writing of the manuscript: MM; restructuring 
and improvement of the contents: DR, LM-S, and DS; and design-
ing the figures: MM and DS.
ACKNOwLeDGMeNTS
This study was supported by the Biotechnology and Biological 
Sciences Research Council (grant numbers BB/M008681/1 and 
BBS/E/I/00001852) and The British Council (grant number 
172710323). We are thankful to Peter Stäheli, Daniel Schnepf, and 
Mirjam Schilling (all from Freiburg, Germany) for their valuable 
comments and suggestions.
FUNDiNG
Funding agencies have no role in design of the manuscript, nature 
of publication, and type of the manuscript.
ReFeReNCeS
1. Randall RE, Goodbourn S. Interferons and viruses: an interplay between 
induction, signalling, antiviral responses and virus countermeasures. J Gen 
Virol (2008) 89(Pt 1):1–47. doi:10.1099/vir.0.83391-0 
2. Baron S, Dianzani F. The interferons: a biological system with thera-
peutic potential in viral infections. Antiviral Res (1994) 24(2–3):97–110. 
doi:10.1016/0166-3542(94)90058-2 
3. Fensterl V, Sen GC. Interferons and viral infections. Biofactors (2009) 
35(1):14–20. doi:10.1002/biof.6 
4. Rathinam VA, Fitzgerald KA. Innate immune sensing of DNA viruses. 
Virology (2011) 411(2):153–62. doi:10.1016/j.virol.2011.02.003 
5. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. 
A diverse range of gene products are effectors of the type I interferon anti-
viral response. Nature (2011) 472(7344):481–5. doi:10.1038/nature09907 
6. Diner BA, Lum KK, Cristea IM. The emerging role of nuclear viral DNA sen-
sors. J Biol Chem (2015) 290(44):26412–21. doi:10.1074/jbc.R115.652289 
7. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev (2004) 
18(18):2195–224. doi:10.1101/gad.1228704 
8. Munir M. TRIM proteins: another class of viral victims. Sci Signal (2010) 
3(118):jc2. doi:10.1126/scisignal.3118jc2 
9. Schlee M, Hartmann G. Discriminating self from non-self in nucleic acid 
sensing. Nat Rev Immunol (2016) 16(9):566–80. doi:10.1038/nri.2016.78 
10. Uchikawa E, Lethier M, Malet H, Brunel J, Gerlier D, Cusack S. Structural 
analysis of dsRNA binding to anti-viral pattern recognition receptors LGP2 
and MDA5. Mol Cell (2016) 62(4):586–602. doi:10.1016/j.molcel.2016.04.021 
11. Karpala AJ, Stewart C, McKay J, Lowenthal JW, Bean AG. Characterization 
of chicken Mda5 activity: regulation of IFN-beta in the absence of 
RIG-I functionality. J Immunol (2011) 186(9):5397–405. doi:10.4049/
jimmunol.1003712 
12. Liniger M, Summerfield A, Zimmer G, McCullough KC, Ruggli N. Chicken 
cells sense influenza A virus infection through MDA5 and CARDIF signal-
ing involving LGP2. J Virol (2012) 86(2):705–17. doi:10.1128/JVI.00742-11 
13. Hayashi T, Watanabe C, Suzuki Y, Tanikawa T, Uchida Y, Saito T. Chicken 
MDA5 senses short double-stranded RNA with implications for antiviral 
response against avian influenza viruses in chicken. J Innate Immun (2014) 
6(1):58–71. doi:10.1159/000351583 
14. Barber MRW, Aldridge JR Jr., Webster RG, Magor KE. Association of RIG-I 
with innate immunity of ducks to influenza. Proc Natl Acad Sci U S A 
(2010) 107(13):5913–8. doi:10.1073/pnas.1001755107 
15. Shao Q, Xu W, Yan L, Liu J, Rui L, Xiao X, et al. Function of duck RIG-I 
in induction of antiviral response against IBDV and avian influenza 
virus on chicken cells. Virus Res (2014) 191:184–91. doi:10.1016/j.
virusres.2014.07.028 
16. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, et  al. 
The evolution of vertebrate toll-like receptors. Proc Natl Acad Sci U S A 
(2005) 102(27):9577–82. doi:10.1073/pnas.0502272102 
17. Keestra AM, de Zoete MR, Bouwman LI, Vaezirad MM, van Putten JPM. 
Unique features of chicken toll-like receptors. Dev Comp Immunol (2013) 
41(3):316–23. doi:10.1016/j.dci.2013.04.009 
18. de Zoete MR, Bouwman LI, Keestra AM, van Putten JPM. Cleavage and 
activation of a toll-like receptor by microbial proteases. Proc Natl Acad Sci 
U S A (2011) 108(12):4968–73. doi:10.1073/pnas.1018135108 
19. Keestra AM, van Putten JPM. Unique properties of the chicken TLR4/
MD-2 complex: selective lipopolysaccharide activation of the MyD88-
dependent pathway. J Immunol (2008) 181(6):4354–62. doi:10.4049/
jimmunol.181.6.4354 
20. Cavlar T, Ablasser A, Hornung V. Induction of type I IFNs by intracel-
lular DNA-sensing pathways. Immunol Cell Biol (2012) 90(5):474–82. 
doi:10.1038/icb.2012.11 
21. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, 
et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 
(2010) 11(11):997–1004. doi:10.1038/ni.1932 
22. Cridland JA, Curley EZ, Wykes MN, Schroder K, Sweet MJ, Roberts 
TL, et  al. The mammalian PYHIN gene family: phylogeny, evolution 
and expression. BMC Evol Biol (2012) 12:140. doi:10.1186/1471-2148- 
12-140 
23. Cheng YQ, Sun YJ, Wang HA, Yan YX, Ding C, Sun JH. Chicken STING 
mediates activation of the IFN gene independently of the RIG-I gene. 
J Immunol (2015) 195(8):3922–36. doi:10.4049/jimmunol.1500638 
24. Wang Z, Ning Z, Sun M, Gao S, Kang Y, Xie P, et al. Interferon regulatory 
factor 7- (IRF7-) mediated immune response affects Newcastle disease 
virus replication in chicken embryo fibroblasts. Acta Vet Hung (2014) 
62(4):500–11. doi:10.1556/AVet.2014.023 
25. Kim TH, Zhou H. Functional analysis of chicken IRF7 in response to dsRNA 
analog poly(I:C) by integrating overexpression and knockdown. PLoS One 
(2015) 10(7):e0133450. doi:10.1371/journal.pone.0133450 
26. May DL, Grant CE, Deeley RG. Cloning and promoter analysis of the 
chicken interferon regulatory factor-3 gene. DNA Cell Biol (2000) 
19(9):555–66. doi:10.1089/104454900439782 
27. Barjesteh N, Abdelaziz KT, Sharif S. The role of IRF7 and NF-κB pathways 
in the induction of antiviral responses in chicken tracheal epithelial cells 
following exposure to TLR3 and 4 ligands. Poster in Veterinary and 
Comparative Immunology (2016). Available from: https://immunology2016.
zerista.com/event/member/256436
28. Zhang G, Jarvis ED, Gilbert MT. Avian genomes. A flock of genomes. 
Introduction. Science (2014) 346(6215):1308–9. doi:10.1126/science.346. 
6215.1308 
29. Eory L, Gilbert MT, Li C, Li B, Archibald A, Aken BL, et  al. Avianbase: 
a community resource for bird genomics. Genome Biol (2015) 16:21. 
doi:10.1186/s13059-015-0588-2 
30. Rubin CJ, Zody MC, Eriksson J, Meadows JR, Sherwood E, Webster MT, 
et  al. Whole-genome resequencing reveals loci under selection during 
chicken domestication. Nature (2010) 464(7288):587–91. doi:10.1038/
nature08832 
31. Albalat R, Canestro C. Evolution by gene loss. Nat Rev Genet (2016) 
17(7):379–91. doi:10.1038/nrg.2016.39 
32. Demuth JP, De Bie T, Stajich JE, Cristianini N, Hahn MW. The evolution 
of mammalian gene families. PLoS One (2006) 1:e85. doi:10.1371/journal.
pone.0000085 
15
Santhakumar et al. Antiviral Effect of Avian Interferons
Frontiers in Immunology | www.frontiersin.org January 2017 | Volume 8 | Article 49
33. Zhou X, Michal JJ, Zhang L, Ding B, Lunney JK, Liu B, et  al. Interferon 
induced IFIT family genes in host antiviral defense. Int J Biol Sci (2013) 
9(2):200–8. doi:10.7150/ijbs.5613 
34. Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT 
and IFITM proteins. Nat Rev Immunol (2013) 13(1):46–57. doi:10.1038/
nri3344 
35. Kaiser P, Wain HM, Rothwell L. Structure of the chicken interferon-gamma 
gene, and comparison to mammalian homologues. Gene (1998) 207(1):25–
32. doi:10.1016/S0378-1119(97)00600-8 
36. Staeheli P, Puehler F, Schneider K, Gobel TW, Kaspers B. Cytokines of 
birds: conserved functions – a largely different look. J Interferon Cytokine 
Res (2001) 21(12):993–1010. doi:10.1089/107999001317205123 
37. Lutfalla G, Roest Crollius H, Stange-Thomann N, Jaillon O, Mogensen K, 
Monneron D. Comparative genomic analysis reveals independent expansion 
of a lineage-specific gene family in vertebrates: the class II cytokine receptors 
and their ligands in mammals and fish. BMC Genomics (2003) 4(1):29. 
doi:10.1186/1471-2164-4-29 
38. Roberts RM, Liu L, Guo Q, Leaman D, Bixby J. The evolution of the type 
I interferons. J Interferon Cytokine Res (1998) 18(10):805–16. doi:10.1089/
jir.1998.18.805 
39. Hughes AL, Roberts RM. Independent origin of IFN-alpha and IFN-beta 
in birds and mammals. J Interferon Cytokine Res (2000) 20(8):737–9. 
doi:10.1089/10799900050116444 
40. Goossens KE, Karpala AJ, Rohringer A, Ward A, Bean AG. Characterisation 
of chicken viperin. Mol Immunol (2015) 63(2):373–80. doi:10.1016/j.
molimm.2014.09.011 
41. Goossens KE, Karpala AJ, Ward A, Bean AG. Characterisation of chicken 
ZAP. Dev Comp Immunol (2014) 46(2):373–81. doi:10.1016/j.dci.2014. 
05.011 
42. Sarmento L, Afonso CL, Estevez C, Wasilenko J, Pantin-Jackwood M. 
Differential host gene expression in cells infected with highly pathogenic 
H5N1 avian influenza viruses. Vet Immunol Immunopathol (2008) 
125(3–4):291–302. doi:10.1016/j.vetimm.2008.05.021 
43. Xia C, Liu J, Wu ZG, Lin CY, Wang M. The interferon-alpha genes from three 
chicken lines and its effects on H9N2 influenza viruses. Anim Biotechnol 
(2004) 15(1):77–88. doi:10.1081/ABIO-120037900 
44. Pei J, Sekellick MJ, Marcus PI, Choi IS, Collisson EW. Chicken interferon 
type I inhibits infectious bronchitis virus replication and associated 
respiratory illness. J Interferon Cytokine Res (2001) 21(12):1071–7. 
doi:10.1089/107999001317205204 
45. Mo CW, Cao YC, Lim BL. The in  vivo and in  vitro effects of chicken 
interferon alpha on infectious bursal disease virus and Newcastle disease 
virus infection. Avian Dis (2001) 45(2):389–99. doi:10.2307/1592978 
46. Levy AM, Heller ED, Leitner G, Davidson I. Effect of native chicken 
interferon on MDV replication. Acta Virol (1999) 43(2–3):121–7. 
47. Penski N, Hartle S, Rubbenstroth D, Krohmann C, Ruggli N, Schusser B, 
et  al. Highly pathogenic avian influenza viruses do not inhibit interferon 
synthesis in infected chickens but can override the interferon-induced 
antiviral state. J Virol (2011) 85(15):7730–41. doi:10.1128/JVI.00063-11 
48. Fringuelli E, Urbanelli L, Tharuni O, Proietti PC, Bietta A, Davidson I, et al. 
Cloning and expression of pigeon IFN-gamma gene. Res Vet Sci (2010) 
89(3):367–72. doi:10.1016/j.rvsc.2010.03.021 
49. Farnell MB, El Halawani M, You S, McElroy AP, Hargis BM, Caldwell 
DJ. In  vivo biologic effects of recombinant-turkey interferon-gamma in 
neonatal leghorn chicks: protection against Salmonella enteritidis organ 
invasion. Avian Dis (2001) 45(2):473–8. doi:10.2307/1592991 
50. Karpala AJ, Morris KR, Broadway MM, McWaters PG, O’Neil TE, Goossens 
KE, et  al. Molecular cloning, expression, and characterization of chicken 
IFN-lambda. J Interferon Cytokine Res (2008) 28(6):341–50. doi:10.1089/
jir.2007.0117 
51. Kaiser P, Poh TY, Rothwell L, Avery S, Balu S, Pathania US, et al. A genomic 
analysis of chicken cytokines and chemokines. J Interferon Cytokine Res 
(2005) 25(8):467–84. doi:10.1089/jir.2005.25.467 
52. Reuter A, Soubies S, Hartle S, Schusser B, Kaspers B, Staeheli P, et  al. 
Antiviral activity of lambda interferon in chickens. J Virol (2014) 
88(5):2835–43. doi:10.1128/JVI.02764-13 
53. Sick C, Schultz U, Staeheli P. A family of genes coding for two serolog-
ically distinct chicken interferons. J Biol Chem (1996) 271(13):7635–9. 
doi:10.1074/jbc.271.13.7635 
54. Goossens KE, Ward AC, Lowenthal JW, Bean AG. Chicken interferons, 
their receptors and interferon-stimulated genes. Dev Comp Immunol (2013) 
41(3):370–6. doi:10.1016/j.dci.2013.05.020 
55. Li HT, Ma B, Mi JW, Jin HY, Xu LN, Wang JW. Cloning, in vitro expression 
and bioactivity of goose interferon-alpha. Cytokine (2006) 34(3–4):177–83. 
doi:10.1016/j.cyto.2006.04.013 
56. Jiang H, Yang H, Kapczynski DR. Chicken interferon alpha pretreatment 
reduces virus replication of pandemic H1N1 and H5N9 avian influenza 
viruses in lung cell cultures from different avian species. Virol J (2011) 
8:447. doi:10.1186/1743-422X-8-447 
57. Hertzog PJ, Williams BR. Fine tuning type I interferon responses. Cytokine 
Growth Factor Rev (2013) 24(3):217–25. doi:10.1016/j.cytogfr.2013.04.002 
58. Guo SY, Li C, Dai XM, Zhao C, Chang WS. Distribution of the type I inter-
feron in different organs of chicken digestive system. Cent Eur J Immunol 
(2014) 39(4):455–60. doi:10.5114/ceji.2014.47728 
59. Zhou H, Chen S, Wang M, Cheng A. Interferons and their receptors 
in birds: a comparison of gene structure, phylogenetic analysis, and 
cross modulation. Int J Mol Sci (2014) 15(11):21045–68. doi:10.3390/ 
ijms151121045 
60. Sekellick MJ, Ferrandino AF, Hopkins DA, Marcus PI. Chicken interferon 
gene: cloning, expression, and analysis. J Interferon Res (1994) 14(2):71–9. 
doi:10.1089/jir.1994.14.71 
61. Meng S, Yang L, Xu C, Qin Z, Xu H, Wang Y, et al. Recombinant chicken 
interferon-alpha inhibits H9N2 avian influenza virus replication in  vivo 
by oral administration. J Interferon Cytokine Res (2011) 31(7):533–8. 
doi:10.1089/jir.2010.0123 
62. Qu H, Yang L, Meng S, Xu L, Bi Y, Jia X, et  al. The differential antiviral 
activities of chicken interferon alpha (ChIFN-alpha) and ChIFN-beta are 
related to distinct interferon-stimulated gene expression. PLoS One (2013) 
8(3):e59307. doi:10.1371/journal.pone.0059307 
63. Masuda Y, Matsuda A, Usui T, Sugai T, Asano A, Yamano Y. Biological 
effects of chicken type III interferon on expression of interferon-stimulated 
genes in chickens: comparison with type I and type II interferons. J Vet 
Med Sci (2012) 74(11):1381–6. doi:10.1292/jvms.11-0517 
64. Sick C, Schultz U, Munster U, Meier J, Kaspers B, Staeheli P. Promoter 
structures and differential responses to viral and nonviral inducers of 
chicken type I interferon genes. J Biol Chem (1998) 273(16):9749–54. 
doi:10.1074/jbc.273.16.9749 
65. Karpala AJ, Bagnaud-Baule A, Goossens KE, Lowenthal JW, Bean AG. 
Ontogeny of the interferon system in chickens. J Reprod Immunol (2012) 
94(2):169–74. doi:10.1016/j.jri.2012.02.008 
66. Karpala AJ, Lowenthal JW, Bean AG. Activation of the TLR3 pathway 
regulates IFNbeta production in chickens. Dev Comp Immunol (2008) 
32(4):435–44. doi:10.1016/j.dci.2007.08.004 
67. Hata N, Sato M, Takaoka A, Asagiri M, Tanaka N, Taniguchi T. Constitutive 
IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by 
virus. Biochem Biophys Res Commun (2001) 285(2):518–25. doi:10.1006/
bbrc.2001.5159 
68. Ziegler RE, Joklik WK. Effect of interferon on multiplication of avian 
sarcoma virus B77 in duck embryo fibroblasts. J Interferon Res (1981) 
1(4):521–38. doi:10.1089/jir.1981.1.521 
69. Schultz U, Kock J, Schlicht HJ, Staeheli P. Recombinant duck interferon: a 
new reagent for studying the mode of interferon action against hepatitis B 
virus. Virology (1995) 212(2):641–9. doi:10.1006/viro.1995.1522 
70. Tian L, Zhao P, Ma B, Guo G, Sun Y, Xing M. Cloning, expression and 
antiviral bioactivity of red-crowned crane interferon-alpha. Gene (2014) 
544(1):49–55. doi:10.1016/j.gene.2014.04.036 
71. Suresh M, Karaca K, Foster D, Sharma JM. Molecular and functional 
characterization of turkey interferon. J Virol (1995) 69(12):8159–63. 
72. Han CL, Zhang W, Dong HT, Han X, Wang M. A novel gene of beta 
chain of the IFN-gamma receptor of Huiyang chicken: cloning, distribution, 
and CD assay. J Interferon Cytokine Res (2006) 26(7):441–8. doi:10.1089/
jir.2006.26.441 
73. Han X, Chen T, Wang M. Molecular cloning and characterization of chicken 
interferon-gamma receptor alpha-chain. J Interferon Cytokine Res (2008) 
28(7):445–54. doi:10.1089/jir.2007.0135 
74. Digby MR, Lowenthal JW. Cloning and expression of the chicken 
interferon-gamma gene. J Interferon Cytokine Res (1995) 15(11):939–45. 
doi:10.1089/jir.1995.15.939 
16
Santhakumar et al. Antiviral Effect of Avian Interferons
Frontiers in Immunology | www.frontiersin.org January 2017 | Volume 8 | Article 49
75. Haq K, Wootton SK, Barjesteh N, St Paul M, Golovan S, Bendall AJ, et al. 
Small interfering RNA-mediated knockdown of chicken interferon-gamma 
expression. J Interferon Cytokine Res (2013) 33(6):319–27. doi:10.1089/
jir.2012.0141 
76. Yuk SS, Lee DH, Park JK, Tseren-Ochir EO, Kwon JH, Noh JY, et al. Pre-
immune state induced by chicken interferon gamma inhibits the replication 
of H1N1 human and H9N2 avian influenza viruses in chicken embryo 
fibroblasts. Virol J (2016) 13:71. doi:10.1186/s12985-016-0527-1 
77. Haq K, Wootton SK, Barjesteh N, Golovan S, Bendall A, Sharif S. Effects 
of interferon-gamma knockdown on vaccine-induced immunity against 
Marek’s disease in chickens. Can J Vet Res (2015) 79(1):1–7. 
78. Sawant PM, Verma PC, Subudhi PK, Chaturvedi U, Singh M, Kumar R, 
et  al. Immunomodulation of bivalent Newcastle disease DNA vaccine 
induced immune response by co-delivery of chicken IFN-gamma and IL-4 
genes. Vet Immunol Immunopathol (2011) 144(1–2):36–44. doi:10.1016/ 
j.vetimm.2011.07.006 
79. Susta L, Cornax I, Diel DG, Garcia SC, Miller PJ, Liu X, et al. Expression 
of interferon gamma by a highly virulent strain of Newcastle disease virus 
decreases its pathogenicity in chickens. Microb Pathog (2013) 61-62:73–83. 
doi:10.1016/j.micpath.2013.05.009 
80. Mallick AI, Parvizi P, Read LR, Nagy E, Behboudi S, Sharif S. Enhancement 
of immunogenicity of a virosome-based avian influenza vaccine in chickens 
by incorporating CpG-ODN. Vaccine (2011) 29(8):1657–65. doi:10.1016/j.
vaccine.2010.12.046 
81. Lavine JE, Ganem D. Inhibition of duck hepatitis B virus replication by inter-
feron-gamma. J Med Virol (1993) 40(1):59–64. doi:10.1002/jmv.1890400112 
82. Schultz U, Chisari FV. Recombinant duck interferon gamma inhibits 
duck hepatitis B virus replication in primary hepatocytes. J Virol (1999) 
73(4):3162–8. 
83. Huang A, Scougall CA, Lowenthal JW, Jilbert AR, Kotlarski I. Structural 
and functional homology between duck and chicken interferon-gamma. Dev 
Comp Immunol (2001) 25(1):55–68. doi:10.1016/S0145-305X(00)00041-0 
84. O’Brien TR, Prokunina-Olsson L, Donnelly RP. IFN-lambda4: the paradox-
ical new member of the interferon lambda family. J Interferon Cytokine Res 
(2014) 34(11):829–38. doi:10.1089/jir.2013.0136 
85. Zhang Z, Zou T, Hu X, Jin H. Type III interferon gene expression in response 
to influenza virus infection in chicken and duck embryonic fibroblasts. 
Mol Immunol (2015) 68(2 Pt C):657–62. doi:10.1016/j.molimm.2015.10.013 
86. Yao Q, Fischer KP, Arnesen K, Tyrrell DL, Gutfreund KS. Molecular cloning, 
expression and characterization of Pekin duck interferon-lambda. Gene 
(2014) 548(1):29–38. doi:10.1016/j.gene.2014.06.066 
87. Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, 
et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity 
through binding in the activation loop. EMBO J (1999) 18(5):1309–20. 
doi:10.1093/emboj/18.5.1309 
88. Kessler DS, Veals SA, Fu XY, Levy DE. Interferon-alpha regulates nuclear 
translocation and DNA-binding affinity of ISGF3, a multimeric tran-
scriptional activator. Genes Dev (1990) 4(10):1753–65. doi:10.1101/gad.4. 
10.1753 
89. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, et  al. 
Functional classification of interferon-stimulated genes identified using 
microarrays. J Leukoc Biol (2001) 69(6):912–20. 
90. To KK, Lau CC, Woo PC, Lau SK, Chan JF, Chan KH, et  al. Human 
H7N9 virus induces a more pronounced pro-inflammatory cytokine but 
an attenuated interferon response in human bronchial epithelial cells when 
compared with an epidemiologically-linked chicken H7N9 virus. Virol J 
(2016) 13:42. doi:10.1186/s12985-016-0498-2 
91. Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: 
a complex web of host defenses. Annu Rev Immunol (2014) 32:513–45. 
doi:10.1146/annurev-immunol-032713-120231 
92. Giotis ES, Robey RC, Skinner NG, Tomlinson CD, Goodbourn S, Skinner 
MA. Chicken interferome: avian interferon-stimulated genes identified by 
microarray and RNA-seq of primary chick embryo fibroblasts treated with a 
chicken type I interferon (IFN-alpha). Vet Res (2016) 47(1):75. doi:10.1186/
s13567-016-0363-8 
93. Kang Y, Feng M, Zhao X, Dai X, Xiang B, Gao P, et al. Newcastle disease 
virus infection in chicken embryonic fibroblasts but not duck embryonic 
fibroblasts is associated with elevated host innate immune response. Virol 
J (2016) 13:41. doi:10.1186/s12985-016-0499-1 
94. Smith SE, Gibson MS, Wash RS, Ferrara F, Wright E, Temperton N, 
et  al. Chicken interferon-inducible transmembrane protein 3 restricts 
influenza viruses and lyssaviruses in vitro. J Virol (2013) 87(23):12957–66. 
doi:10.1128/JVI.01443-13 
95. Zhang Y, Fu D, Chen H, Zhang Z, Shi Q, Elsayed AK, et al. Partial antiviral 
activities detection of chicken Mx jointing with neuraminidase gene (NA) 
against Newcastle disease virus. PLoS One (2013) 8(8):e71688. doi:10.1371/
journal.pone.0071688 
96. Gao G, Guo X, Goff SP. Inhibition of retroviral RNA production by 
ZAP, a CCCH-type zinc finger protein. Science (2002) 297(5587):1703–6. 
doi:10.1126/science.1074276 
97. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, Kashigi 
F, et  al. ZAPS is a potent stimulator of signaling mediated by the RNA 
helicase RIG-I during antiviral responses. Nat Immunol (2011) 12(1):37–44. 
doi:10.1038/ni.1963 
98. Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, Lopez CB, et  al. 
Palmitoylome profiling reveals S-palmitoylation-dependent antiviral 
activity of IFITM3. Nat Chem Biol (2010) 6(8):610–4. doi:10.1038/ 
nchembio.405 
99. Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, et  al. 
IFITM proteins restrict viral membrane hemifusion. PLoS Pathog (2013) 
9(1):e1003124. doi:10.1371/journal.ppat.1003124 
100. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M, et al. 
The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis 
to block viral entry. Cell Host Microbe (2013) 13(4):452–64. doi:10.1016/j.
chom.2013.03.006 
101. Blyth GA, Chan WF, Webster RG, Magor KE. Duck interferon-inducible 
transmembrane protein 3 mediates restriction of influenza viruses. J Virol 
(2015) 90(1):103–16. doi:10.1128/JVI.01593-15 
102. Haller O, Gao S, von der Malsburg A, Daumke O, Kochs G. Dynamin-like 
MxA GTPase: structural insights into oligomerization and implications for 
antiviral activity. J Biol Chem (2010) 285(37):28419–24. doi:10.1074/jbc.
R110.145839 
103. Haller O, Kochs G. Human MxA protein: an interferon-induced dynamin-
like GTPase with broad antiviral activity. J Interferon Cytokine Res (2011) 
31(1):79–87. doi:10.1089/jir.2010.0076 
104. Haller O, Staeheli P, Schwemmle M, Kochs G. Mx GTPases: dynamin-
like antiviral machines of innate immunity. Trends Microbiol (2015) 
23(3):154–63. doi:10.1016/j.tim.2014.12.003 
105. Verhelst J, Hulpiau P, Saelens X. Mx proteins: antiviral gatekeepers that 
restrain the uninvited (vol 77, pg 551, 2013). Microbiol Mol Biol Rev (2014) 
78(1):198–198. doi:10.1128/MMBR.00011-14 
106. Goujon C, Moncorge O, Bauby H, Doyle T, Ward CC, Schaller T, et  al. 
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 
infection. Nature (2013) 502(7472):559–62. doi:10.1038/nature12542 
107. Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, et al. The interferon- inducible 
MxB protein inhibits HIV-1 infection. Cell Host Microbe (2013) 14(4):398–
410. doi:10.1016/j.chom.2013.08.015 
108. Verhelst J, Hulpiau P, Saelens X. Mx proteins: antiviral gatekeepers that 
restrain the uninvited. Microbiol Mol Biol Rev (2013) 77(4):551–66. 
doi:10.1128/MMBR.00024-13 
109. Zeng M, Chen S, Wang MS, Jia RY, Zhu DK, Liu MF, et al. Molecular iden-
tification and comparative transcriptional analysis of myxovirus resistance 
GTPase (Mx) gene in goose (Anser cygnoide) after H9N2 AIV infection. 
Comp Immunol Microbiol Infect Dis (2016) 47:32–40. doi:10.1016/j.
cimid.2016.05.005 
110. Bernasconi D, Schultz U, Staeheli P. The interferon-induced Mx protein 
of chickens lacks antiviral activity. J Interferon Cytokine Res (1995) 
15(1):47–53. doi:10.1089/jir.1995.15.47 
111. Bazzigher L, Schwarz A, Staeheli P. No enhanced influenza virus resistance 
of murine and avian cells expressing cloned duck Mx protein. Virology 
(1993) 195(1):100–12. doi:10.1006/viro.1993.1350 
112. Benfield CT, Lyall JW, Tiley LS. The cytoplasmic location of chicken Mx is 
not the determining factor for its lack of antiviral activity. PLoS One (2010) 
5(8):e12151. doi:10.1371/journal.pone.0012151 
113. Schusser B, Reuter A, von der Malsburg A, Penski N, Weigend S, Kaspers 
B, et  al. Mx is dispensable for interferon-mediated resistance of chicken 
cells against influenza A virus. J Virol (2011) 85(16):8307–15. doi:10.1128/
JVI.00535-11 
17
Santhakumar et al. Antiviral Effect of Avian Interferons
Frontiers in Immunology | www.frontiersin.org January 2017 | Volume 8 | Article 49
114. Ko JH, Jin HK, Asano A, Takada A, Ninomiya A, Kida H, et  al. 
Polymorphisms and the differential antiviral activity of the chicken Mx 
gene. Genome Res (2002) 12(4):595–601. doi:10.1101/gr.210702 
115. Ko JH, Takada A, Mitsuhashi T, Agui T, Watanabe T. Native antiviral 
specificity of chicken Mx protein depends on amino acid variation at 
position 631. Anim Genet (2004) 35(2):119–22. doi:10.1111/j.1365-2052. 
2004.01096.x 
116. Sasaki K, Yoneda A, Ninomiya A, Kawahara M, Watanabe T. Both antiviral 
activity and intracellular localization of chicken Mx protein depend on a 
polymorphism at amino acid position 631. Biochem Biophys Res Commun 
(2013) 430(1):161–6. doi:10.1016/j.bbrc.2012.11.053 
117. Li B, Fu D, Zhang Y, Xu Q, Ni L, Chang G, et  al. Partial antiviral 
activities of the Asn631 chicken Mx against Newcastle disease virus and 
vesicular stomatitis virus. Mol Biol Rep (2012) 39(8):8415–24. doi:10.1007/
s11033-012-1694-9 
118. Yin YL, Huang RL, Li TJ, Ruan Z, Xie MY, Deng ZY, et  al. Amino 
acid metabolism in the portal-drained viscera of young pigs: effects of 
dietary supplementation with chitosan and pea hull. Amino Acids (2010) 
39(5):1581–7. doi:10.1007/s00726-010-0577-4 
119. Benfield CT, Lyall JW, Kochs G, Tiley LS. Asparagine 631 variants of the 
chicken Mx protein do not inhibit influenza virus replication in primary 
chicken embryo fibroblasts or in  vitro surrogate assays. J Virol (2008) 
82(15):7533–9. doi:10.1128/JVI.00185-08 
120. Ewald SJ, Kapczynski DR, Livant EJ, Suarez DL, Ralph J, McLeod S, et al. 
Association of Mx1 Asn631 variant alleles with reductions in morbidity, 
early mortality, viral shedding, and cytokine responses in chickens infected 
with a highly pathogenic avian influenza virus. Immunogenetics (2011) 
63(6):363–75. doi:10.1007/s00251-010-0509-1 
121. Sironi L, Williams JL, Moreno-Martin AM, Ramelli P, Stella A, Jianlin H, 
et  al. Susceptibility of different chicken lines to H7N1 highly pathogenic 
avian influenza virus and the role of Mx gene polymorphism coding 
amino acid position 631. Virology (2008) 380(1):152–6. doi:10.1016/j.
virol.2008.07.022 
122. Feng GS, Chong K, Kumar A, Williams BR. Identification of double-stranded 
RNA-binding domains in the interferon-induced double-stranded RNA-
activated p68 kinase. Proc Natl Acad Sci U S A (1992) 89(12):5447–51. 
doi:10.1073/pnas.89.12.5447 
123. Metz DH, Esteban M. Interferon inhibits viral protein synthesis in 
L cells infected with vaccinia virus. Nature (1972) 238(5364):385–8. 
doi:10.1038/238385a0 
124. Munir M, Berg M. The multiple faces of proteinkinase R in antiviral defense. 
Virulence (2013) 4(1):85–9. doi:10.4161/viru.23134 
125. Clemens MJ, Elia A. The double-stranded RNA-dependent protein kinase 
PKR: structure and function. J Interferon Cytokine Res (1997) 17(9):503–24. 
doi:10.1089/jir.1997.17.503 
126. Ko JH, Asano A, Kon Y, Watanabe T, Agui T. Characterization of the chicken 
PKR: polymorphism of the gene and antiviral activity against vesicular 
stomatitis virus. Jpn J Vet Res (2004) 51(3–4):123–33. 
127. Daviet S, Van Borm S, Habyarimana A, Ahanda ML, Morin V, Oudin A, 
et  al. Induction of Mx and PKR failed to protect chickens from H5N1 
infection. Viral Immunol (2009) 22(6):467–72. doi:10.1089/vim.2009.0053 
128. Schulz O, Pichlmair A, Rehwinkel J, Rogers NC, Scheuner D, Kato H, 
et al. Protein kinase R contributes to immunity against specific viruses by 
regulating interferon mRNA integrity. Cell Host Microbe (2010) 7(5):354–61. 
doi:10.1016/j.chom.2010.04.007 
129. Hovanessian AG, Kerr IM. The (2’-5’) oligoadenylate (pppA2’-5’A2’-5’A) 
synthetase and protein kinase(s) from interferon-treated cells. Eur J Biochem 
(1979) 93(3):515–26. doi:10.1111/j.1432-1033.1979.tb12850.x 
130. Sokawa J, Shimizu N, Sokawa Y. Presence of (2’-5’)oligoadenylate synthetase 
in avian erythrocytes. J Biochem (1984) 96(1):215–22. 
131. Sokawa J, Sokawa Y. (2’-5’) oligoadenylate synthetase in chicken embryo 
erythrocytes and immature red blood cells. J Biochem (1986) 99(1):119–24. 
132. Yamamoto A, Iwata A, Koh Y, Kawai S, Murayama S, Hamada K, et al. Two 
types of chicken 2’,5’-oligoadenylate synthetase mRNA derived from alleles 
at a single locus. Biochim Biophys Acta (1998) 1395(2):181–91. doi:10.1016/
S0167-4781(97)00148-6 
133. Tatsumi R, Hamada K, Sekiya S, Wakamatsu M, Namikawa T, Mizutani 
M, et  al. 2’,5’-oligoadenylate synthetase gene in chicken: gene structure, 
distribution of alleles and their expression. Biochim Biophys Acta (2000) 
1494(3):263–8. doi:10.1016/S0167-4781(00)00174-3 
134. Tatsumi R, Sekiya S, Nakanishi R, Mizutani M, Kojima S, Sokawa Y. 
Function of ubiquitin-like domain of chicken 2’-5’-oligoadenylate synthetase 
in conformational stability. J Interferon Cytokine Res (2003) 23(11):667–76. 
doi:10.1089/107999003322558809 
135. West DK, Ball LA. Induction and maintenance of 2’,5’-oligoadenylate 
synthetase in interferon-treated chicken embryo cells. Mol Cell Biol (1982) 
2(11):1436–43. doi:10.1128/MCB.2.11.1436 
136. Tag-El-Din-Hassan HT, Sasaki N, Moritoh K, Torigoe D, Maeda A, Agui 
T. The chicken 2’-5’ oligoadenylate synthetase A inhibits the replication of 
West Nile virus. Jpn J Vet Res (2012) 60(2–3):95–103. 
137. Hinson ER, Cresswell P. The N-terminal amphipathic alpha-helix of viperin 
mediates localization to the cytosolic face of the endoplasmic reticulum and 
inhibits protein secretion. J Biol Chem (2009) 284(7):4705–12. doi:10.1074/
jbc.M807261200 
138. Wang X, Hinson ER, Cresswell P. The interferon-inducible protein viperin 
inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 
(2007) 2(2):96–105. doi:10.1016/j.chom.2007.06.009 
139. Tan KS, Olfat F, Phoon MC, Hsu JP, Howe JL, Seet JE, et  al. In vivo and 
in  vitro studies on the antiviral activities of viperin against influenza 
H1N1 virus infection. J Gen Virol (2012) 93(Pt 6):1269–77. doi:10.1099/
vir.0.040824-0 
140. Isaacs A, Lindenmann J. Virus interference. I. The interferon. By A. Isaacs 
and J. Lindenmann, 1957. J Interferon Res (1987) 7(5):429–38. doi:10.1089/
jir.1987.7.429 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.
Copyright © 2017 Santhakumar, Rubbenstroth, Martinez-Sobrido and Munir. This 
is an open-access article distributed under the terms of the Creative Commons 
Attribution License (CC BY). The use, distribution or reproduction in other forums 
is permitted, provided the original author(s) or licensor are credited and that the 
original publication in this journal is cited, in accordance with accepted academic 
practice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
